Drug wars how big pharma raises prices and keeps generics off the market
While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frond...
| Main Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Cambridge
Cambridge University Press
2017
|
| Subjects: | |
| Online Access: | |
| Collection: | Cambridge Books Online - Collection details see MPG.ReNa |
Table of Contents:
- Machine generated contents note: Introduction: big scandals, higher prices; 1. The winding road to generic entry; 2. 'Generation 1.0': the rise and fall of traditional pay-for-delay; 3. 'Generation 2.0': complicating pay-for-delay; 4. 'Generation 3.0': new tactics for active obstruction of generics; 5. 'Generation 3.0' continued: obstruction of regulatory pathways; 6. Empirical evidence of a citizen's pathway gone astray; Conclusion: a call for systematic reform